Pharmanutra Past Earnings Performance
Past criteria checks 2/6
Pharmanutra has been growing earnings at an average annual rate of 15.3%, while the Personal Products industry saw earnings growing at 6.6% annually. Revenues have been growing at an average rate of 14.9% per year. Pharmanutra's return on equity is 28.8%, and it has net margins of 15.1%.
Key information
15.3%
Earnings growth rate
14.8%
EPS growth rate
| Personal Products Industry Growth | 6.6% |
| Revenue growth rate | 14.9% |
| Return on equity | 28.8% |
| Net Margin | 15.1% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Pharmanutra makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 93 | 14 | 18 | 0 |
| 31 Mar 23 | 88 | 17 | 18 | 0 |
| 31 Dec 22 | 83 | 15 | 17 | 0 |
| 30 Sep 22 | 79 | 16 | 15 | 0 |
| 30 Jun 22 | 76 | 15 | 14 | 0 |
| 31 Mar 22 | 73 | 15 | 13 | 0 |
| 31 Dec 21 | 68 | 14 | 12 | 0 |
| 30 Sep 21 | 65 | 14 | 12 | 0 |
| 30 Jun 21 | 60 | 11 | 11 | 0 |
| 31 Mar 21 | 57 | 14 | 10 | 0 |
| 31 Dec 20 | 57 | 14 | 10 | 0 |
| 30 Sep 20 | 58 | 14 | 10 | 0 |
| 30 Jun 20 | 58 | 14 | 10 | 0 |
| 31 Mar 20 | 55 | 9 | 10 | 0 |
| 31 Dec 19 | 54 | 8 | 9 | 0 |
| 30 Sep 19 | 49 | 8 | 8 | 0 |
| 30 Jun 19 | 50 | 9 | 7 | 0 |
| 31 Mar 19 | 48 | 9 | 8 | 0 |
| 31 Dec 18 | 47 | 9 | 8 | 0 |
| 30 Sep 18 | 44 | 8 | 8 | 0 |
| 30 Jun 18 | 41 | 7 | 7 | 0 |
| 31 Mar 18 | 40 | 6 | 7 | 0 |
| 31 Dec 17 | 38 | 6 | 6 | 0 |
| 30 Sep 17 | 37 | 5 | 6 | 0 |
| 30 Jun 17 | 35 | 5 | 5 | 0 |
| 31 Mar 17 | 34 | 4 | 5 | 0 |
| 31 Dec 16 | 33 | 4 | 5 | 0 |
| 31 Dec 15 | 26 | 3 | 5 | 0 |
Quality Earnings: PHNM has a high level of non-cash earnings.
Growing Profit Margin: PHNM's current net profit margins (15.1%) are lower than last year (19.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PHNM's earnings have grown by 15.3% per year over the past 5 years.
Accelerating Growth: PHNM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PHNM had negative earnings growth (-6.1%) over the past year, making it difficult to compare to the Personal Products industry average (42%).
Return on Equity
High ROE: PHNM's Return on Equity (28.8%) is considered high.